Company intelligence / Profile preview

Invetech

Mount Waverley, Victoria, Australiainvetechgroup.com ↗

Ownership: Private
Development stage: Commercial

Overview

Invetech does not develop therapeutics directly and therefore does not report clinical results. The company provides design, engineering, and manufacturing services for advanced instruments and automation systems in diagnostics and cell/gene therapies.

Modalities: Cell therapyDeviceBiologicAutomation platform/device for diagnostics and manufacturingGene therapyRecombinant proteinSmall molecule
Industry: Drug Discovery Services

Partnerships

TreeFrog Therapeutics – GMP stem-cell encapsulation device partnershipOrganovo – co-developed world’s first commercial bioprinterbioMérieux/Labtech Systems – high-throughput culture plate streaking instrumentStemCell Technologies – RoboSep® automated separator

Beyond the preview

Go deeper on Invetech.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Invetech.

Explore the full profile